دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Can artificial intelligence improve cancer care?
doi : 10.1016/S1470-2045(23)00240-1
Volume 24, Issue 6, June 2023, Page 577
Dalpiciclib in advanced breast cancer
Xiaosong Chen, Kunwei Shen
doi : 10.1016/S1470-2045(23)00228-0
Volume 24, Issue 6, June 2023, Pages 578-579
Polygenic risk scores in cancer screening: a glass half full or half empty?
Nora Pashayan, Douglas F Easton, *Kyriaki Michailidou
doi : 10.1016/S1470-2045(23)00217-6
Volume 24, Issue 6, June 2023, Pages 579-581
Enhancing colon cancer care in restricted-resource settings
Laura Von Wallwitz Freitas, *Stephen Stefani
doi : 10.1016/S1470-2045(23)00221-8
Volume 24, Issue 6, June 2023, Pages 581-582
Long-term surgical consequences of childhood cancer
Danny R Youlden, Jason D Pole, Nancy N Baxter, Joanne F Aitken
doi : 10.1016/S1470-2045(23)00166-3
Volume 24, Issue 6, June 2023, Pages 582-583
Cancer research funding data to drive collaboration and inform action
Elise M Garton, Michael Cheetham, Mishka Kohli Cira, Lynne Davies, Panagiota Mitrou, Douglas Puricelli Perin, Anna Laura Ross, Syed Nabeel Zafar, Kalina Duncan
doi : 10.1016/S1470-2045(23)00153-5
Volume 24, Issue 6, June 2023, Pages 584-586
Uterine cancer mortality and Black women: time to act
Esther L Moss, Lucy Teece, *Natalie Darko
doi : 10.1016/S1470-2045(23)00113-4
Volume 24, Issue 6, June 2023, Pages 586-588
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update
Eline L Giraud, Bas de Lijster, Stefanie D Krens, Ingrid M E Desar, Emmy Boerrigter, *Nielka P van Erp
doi : 10.1016/S1470-2045(23)00216-4
Volume 24, Issue 6, June 2023, Page e229
Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma
Dun-Chang Mo, Jian-Feng Huang, Peng-Hui Luo, Xiu-Juan Liang, Han-Lei Wang
doi : 10.1016/S1470-2045(23)00211-5
Volume 24, Issue 6, June 2023, Page e230
Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma – Authors' reply
Dieter Körholz, Christine Mauz-Körholz, *W Hamish Wallace, Judith Landman-Parker, Regine Kluge, Dirk Hasenclever
doi : 10.1016/S1470-2045(23)00235-8
Volume 24, Issue 6, June 2023, Page e231
Artifical intelligence-based model for lymph node metastases detection in bladder cancer
Kang Zou, Muhan Lü, Yan Peng, *Xiaowei Tang
doi : 10.1016/S1470-2045(23)00152-3
Volume 24, Issue 6, June 2023, Page e232
Artificial intelligence-based model for lymph node metastases detection in bladder cancer
Zhipeng Mai, Yi Zhou, Zhien Zhou, *Weigang Yan
doi : 10.1016/S1470-2045(23)00209-7
Volume 24, Issue 6, June 2023, Page e233
Artificial intelligence-based model for lymph node metastases detection in bladder cancer – Authors' reply
Shaoxu Wu, Guibin Hong, *Tianxin Lin
doi : 10.1016/S1470-2045(23)00225-5
Volume 24, Issue 6, June 2023, Page e234
HPV DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia
Abhishek Anil, *Muhammad Aaqib Shamim, Aswini Saravanan, Mokanpally Sandeep
doi : 10.1016/S1470-2045(23)00210-3
Volume 24, Issue 6, June 2023, Page e235
HPV DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia
Rama Jayaraj, Sameep Shetty, Kodiveri Muthukaliannan Gothandam, Samiappan Suja, Yash Merchant
doi : 10.1016/S1470-2045(23)00174-2
Volume 24, Issue 6, June 2023, Page e236
HPV DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia – Authors' reply
Penglin Liu, Zhuang Li, Jinwei Miao, Beihua Kong, *Kun Song
doi : 10.1016/S1470-2045(23)00229-2
Volume 24, Issue 6, June 2023, Page e237
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer – Authors' reply
Stephen R D Johnston, Sara M Tolaney, Joyce O’Shaughnessy, Priya Rastogi, Nadia Harbeck, Miguel Martin
doi : 10.1016/S1470-2045(23)00214-0
Volume 24, Issue 6, June 2023, Page e238
South Africa's new tobacco and e-cigarette control bill
Manjulika Das
doi : 10.1016/S1470-2045(23)00220-6
Volume 24, Issue 6, June 2023, Page e239
G7 Cancer: the priorities and challenges ahead
Kathryn Senior
doi : 10.1016/S1470-2045(23)00236-X
Volume 24, Issue 6, June 2023, Page e240
Cancer care desperately impeded by fighting in Gaza
Elizabeth Gourd
doi : 10.1016/S1470-2045(23)00237-1
Volume 24, Issue 6, June 2023, Page e241
New US breast cancer screening recommendations
Priya Venkatesan
doi : 10.1016/S1470-2045(23)00238-3
Volume 24, Issue 6, June 2023, Page e242
ESTRO 2023
Smriti Patodia
doi : 10.1016/S1470-2045(23)00239-5
Volume 24, Issue 6, June 2023, Pages e243-e244
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer
Tomer Meirson, Daniel A Goldstein, Bishal Gyawali, *Ian F Tannock
doi : 10.1016/S1470-2045(23)00165-1
Volume 24, Issue 6, June 2023, Pages 589-593
Preoperative chemoradiotherapy or perioperative chemotherapy for patients with gastro-oesophageal junction adenocarcinoma
doi : 10.1016/S1470-2045(23)00244-9
Volume 24, Issue 6, June 2023, Pages 593-595
Surviving cancer through poetry
Caroline A Kinsey
doi : 10.1016/S1470-2045(23)00245-0
Volume 24, Issue 6, June 2023, Pages 595-596
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial
Karim Fizazi, Ken Herrmann, Bernd J Krause, Kambiz Rahbar, Kim N Chi, Michael J Morris, Oliver Sartor, Scott T Tagawa, Ayse T Kendi, Nicholas Vogelzang, Jeremie Calais, James Nagarajah, Xiao X Wei, Vadim S Koshkin, Jean-Mathieu Beauregard, Brian Chang, Ray Ghouse, Michelle DeSilvio, Richard A Messmann, Johann de Bono
doi : 10.1016/S1470-2045(23)00158-4
10.1016/S1470-2045(23)00158-4
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
Claire Petit, Anne Lee, Jun Ma, Benjamin Lacas, Wai Tong Ng, Anthony T C Chan, Ruey-Long Hong, Ming-Yuan Chen, Lei Chen, Wen-Fei Li, Pei-Yu Huang, Terence Tan, Roger K C Ngan, Guopei Zhu, Hai-Qiang Mai, Edwin P Hui, George Fountzilas, Li Zhang, Alexandra Carmel, Dora L W Kwong, James Moon, Jean Bourhis, Anne Auperin, Jean-Pierre Pignon, Pierre Blanchard, on behalf of the MAC-NPC Collaborative Group
doi : 10.1016/S1470-2045(23)00163-8
Volume 24, Issue 6, June 2023, Pages 611-623
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study
Kristina Jenei, Adam J N Raymakers, Arnaud Bayle, Karin Berger-Thürmel, Avi Cherla, Kazunori Honda, Christopher C G A Jackson, Deme Karikios, Dario Trapani, Scott Berry, Bishal Gyawali
doi : 10.1016/S1470-2045(23)00175-4
Volume 24, Issue 6, June 2023, Pages 624-635
Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments
Stuart A McIntosh, Fareeha Alam, Laura Adams, Ian S Boon, Jonathan Callaghan, Isabella Conti, Ellen Copson, Victoria Carson, Mitchell Davidson, Helen Fitzgerald, Ashram Gautam, Christopher M Jones, Saffron Kargbo, Gokul Lakshmipathy, Hannah Maguire, Kathryn McFerran, Amatta Mirandari, Natasha Moore, Ross Moore, Aidan Murray, Lydia Newman, Stephen D Robinson, Ashvina Segaran, Chin Nam Soong, Andrew Walker, Kusal Wijayaweera, Rifat Atun, Ramsey I Cutress*, Michael G Head
doi : 10.1016/S1470-2045(23)00182-1
Volume 24, Issue 6, June 2023, Pages 636-645
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Pin Zhang*, Qingyuan Zhang*, Zhongsheng Tong, Tao Sun, Wei Li, Quchang Ouyang, Xichun Hu, Ying Cheng, Min Yan, Yueyin Pan, Yuee Teng, Xi Yan, Ying Wang, Weimin Xie, Xiaohua Zeng, Xiaojia Wang, Changlu Hu, Cuizhi Geng, Hongwei Zhang, Wenxin Li, Xinhong Wu, Jincai Zhong, Jingwei Xu, Yanxia Shi, Wenhua Wei, Nayima Bayaxi, Xiaoyu Zhu, Binghe Xu
doi : 10.1016/S1470-2045(23)00172-9
Volume 24, Issue 6, June 2023, Pages 646-657
Utility of polygenic risk scores in UK cancer screening: a modelling analysis
Catherine Huntley*, Bethany Torr*, Amit Sud, Charlie F Rowlands, Rosalind Way, Katie Snape, Helen Hanson, Charles Swanton, John Broggio, Anneke Lucassen, Margaret McCartney, Richard S Houlston, Aroon D Hingorani, Michael E Jones, Clare Turnbull
doi : 10.1016/S1470-2045(23)00156-0
Volume 24, Issue 6, June 2023, Pages 658-668
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Alexandre R Zlotta*, Leslie K Ballas, Andrzej Niemierko†, Katherine Lajkosz†, Cynthia Kuk, Gus Miranda, Michael Drumm, Andrea Mari, Ethan Thio, Neil E Fleshner, Girish S Kulkarni, Michael A S Jewett, Robert G Bristow, Charles Catton, Alejandro Berlin, Srikala S Sridhar, Anne Schuckman, Adam S Feldman, Matthew Wszolek, Douglas M Dahl, Richard J Lee, Philip J Saylor, M Dror Michaelson, David T Miyamoto, Anthony Zietman, William Shipley, Peter Chung, Siamak Daneshmand, Jason A Efstathiou*
doi : 10.1016/S1470-2045(23)00170-5
Volume 24, Issue 6, June 2023, Pages 669-681
Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement
Brooke E Wilson, Christopher M Booth, Richard Sullivan, Ajay Aggarwal, Manju Sengar, Susannah Jacob, Freddie Bray, Michael B Barton, Sallie-Anne Pearson
doi : 10.1016/S1470-2045(23)00183-3
Volume 24, Issue 6, June 2023, Pages 682-690
Cumulative burden of late, major surgical intervention in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) cohort
Bryan V Dieffenbach*, Andrew J Murphy*, Qi Liu, Duncan C Ramsey, Erik J Geiger, Lisa R Diller, Rebecca M Howell, Kevin C Oeffinger, Leslie L Robison, Yutaka Yasui, Gregory T Armstrong, Eric J Chow, Brent R Weil†, Christopher B Weldonâ€
doi : 10.1016/S1470-2045(23)00154-7
Volume 24, Issue 6, June 2023, Pages 691-700
The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry
Tian Chu*, Yifan Meng*, Ping Wu*, Zheng Li *, Hao Wen*, Fang Ren*, Dongling Zou*, Huaiwu Lu*, Lingying Wu*, Shengtao Zhou*, Ying Chen*, Jundong Li, Miaochun Xu, Xiaoliu Wu, Xi Xiong, Zhibin Wang, Misi He, Yuanyuan Zhang, Shitong Lin, Canhui Cao, Wencheng Ding, Yu Chen, Wenhua Zhi, Ting Peng, Ye Wei, Binghan Liu, Yashi Xu, Ding Ma, Jing Wang†, Chaoyang Sun†, Peng Wuâ€
doi : 10.1016/S1470-2045(23)00185-7
Volume 24, Issue 6, June 2023, Pages 701-708
Global democratisation of proton radiotherapy
Tian Chu*, Yifan Meng*, Ping Wu*, Zheng Li *, Hao Wen*, Fang Ren*, Dongling Zou*, Huaiwu Lu*, Lingying Wu*, Shengtao Zhou*, Ying Chen*, Jundong Li, Miaochun Xu, Xiaoliu Wu, Xi Xiong, Zhibin Wang, Misi He, Yuanyuan Zhang, Shitong Lin, Canhui Cao, Wencheng Ding, Yu Chen, Wenhua Zhi, Ting Peng, Ye Wei, Binghan Liu, Yashi Xu, Ding Ma, Jing Wang†, Chaoyang Sun†, Peng Wuâ€
doi : 10.1016/S1470-2045(23)00184-5
Volume 24, Issue 6, June 2023, Pages e245-e254
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Heinz Ludwig, Evangelos Terpos, Niels van de Donk, Maria-Victoria Mateos, Philippe Moreau, Melitios-Athanasios Dimopoulos, Michel Delforge, Paula Rodriguez-Otero, Jesús San-Miguel, Kwee Yong, Francesca Gay, Hermann Einsele, Roberto Mina, Jo Caers, Christoph Driessen, Pellegrino Musto, Sonja Zweegman, Monika Engelhardt, Gordon Cook, Katja Weisel, Annemiek Broijl, Meral Beksac, Jelena Bila, Fredrik Schjesvold, Michele Cavo, Roman Hajek, Cyrille Touzeau, Mario Boccadoro, Pieter Sonneveld
doi : 10.1016/S1470-2045(23)00159-6
Volume 24, Issue 6, June 2023, Pages e255-e269
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
Madeline Pe, Ahu Alanya, Ragnhild Sorum Falk, Cecilie Delphin Amdal, Kristin Bjordal, Jane Chang, Paul Cislo, Corneel Coens, Linda Dirven, Rebecca M Speck, Kristina Fitzgerald, Jayne Galinsky, Johannes M Giesinger, Bernhard Holzner, Saskia Le Cessie, Daniel O’Connor, Kathy Oliver, Vivek Pawar, Chantal Quinten, Michael Schlichting, Jinma Ren, Satrajit Roychoudhury, Martin J B Taphoorn, Galina Velikova, Lisa M Wintner, Ingolf Griebsch, Andrew Bottomley, on behalf of the SISAQOL-IMI Consortium
doi : 10.1016/S1470-2045(23)00157-2
Volume 24, Issue 6, June 2023, Pages e270-e283
Extraskeletal osteosarcoma of primary retroperitoneal origin
Angeline Sapiano, Clifford Caruana, Neville Spiteri, Andre Stefan Gatt, Sarah Degiorgio, Anthony Samuel, David Pisani, Malcolm Buhagiar
doi : 10.1016/S1470-2045(23)00155-9
Volume 24, Issue 6, June 2023, Page e284
